Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	2.02	148.86	-145.91
Graham Fair Price	-23.82	3782.36	4964.96
PEG	202.07	-0.40	0.13
Price/Book	0.58	0.38	0.38
Price/Cash Flow	inf	0.00	48.34
Prices/Earnings	119.90	19.39	8.82
Price/Sales	-22.91	4.36	5.65
Price/FCF	inf	0.00	48.34
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-40.96	0.13	0.22
ROA	-51.41	< 0.005	< 0.005
ROE	0.01	< 0.005	-54.26
ROIC	< 0.005	< 0.005	-27.15
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.49	0.08	475.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.60	-0.16	-73.90
EPS QOQ	0.67	-0.48	-27.20
FCF QOQ	< 0.005	-1.00	-44950.00
Revenue QOQ	-0.14	0.43	203.64
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.79	0.78	-1.33
Quick Ratio	0.35	3.73	968.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	10075.72	11349.29	12.64
Cash	51856.72	50702.29	-2.23
Capex	0.00	0.00	0.00
Free Cash Flow	79.33	0.00	inf
Revenue	678.65	997.36	46.96
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.35	3.79	988.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-171.18	245.56	43.45
Naive Interpretation	Member

06 - Financial Health · Bad

Rating